(WASHINGTON) — Sixteen state attorneys general filed a lawsuit against the Trump administration on Friday over its cancellation of research grants from the National Institutes of Health (NIH).
The suit, filed in the U.S. District Court for the District of Massachusetts, argues the cancellation of the grants is “unlawful” and the attorneys general “seek relief for the unreasonable and intentional delays currently plaguing the grant-application process.”
The defendants named in the suit include the NIH, almost all of the NIH’s 27 institutes and centers, NIH director Dr. Jay Bhattacharya, the Department of Health and Human Services and HHS Secretary Robert F. Kennedy Jr.
The NIH told ABC News it does not comment on pending litigation. The HHS did not immediately reply to ABC News’ request for comment.
“Once again, the Trump administration is putting politics before public health and risking lives and livelihoods in the process,” New York Attorney General Letitia James, one of plaintiffs in the lawsuit, said in a statement. “Millions of Americans depend on our nation’s research institutions for treatments and cures to the diseases that devastate families every day.”
“The decision to cut these funds is an attack on science, public health, and medical innovation — and I won’t stand for it. We are suing to restore these critical funds because the people of New York, and the entire nation, deserve better,” the statement continued.
Over the past several weeks, active research grants related to studies involving LGBTQ+ issues, gender identity and diversity, equity and inclusion (DEI) have been canceled at the NIH because they allegedly do not serve the “priorities” of President Donald Trump’s administration.
As of late March, more than 900 grants worth millions of dollars have been terminated, an NIH official with knowledge of the matter, who asked not to be named, told ABC News.
In previous termination letters, viewed by ABC News, they state that, “Research programs based on gender identity are often unscientific, have little identifiable return on investment, and do nothing to enhance the health of many Americans. Many such studies ignore, rather than seriously examine, biological realities. It is the policy of NIH not to prioritize these research programs.”
“The premise…is incompatible with agency priorities, and no modification of the project could align the project with agency priorities,” the letters continue.
The plaintiffs argue that the terminations, “if left unchecked,” could cause “direct, immediate, significant, and irreparable harm to the plaintiffs and their public research institutions. “
The attorneys general are seeking a preliminary and permanent injunction asking the defendants to review delayed applications and barring them from carrying out terminations of grants.
Earlier this week, researchers who had millions of dollars’ worth of grants terminated by the NIH sued the agency, the HHS, Bhattacharya and Kennedy in the hopes of stopping any further research cancellations.
Copyright © 2025, ABC Audio. All rights reserved.
